Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- The Use of Generative Artificial Intelligence Technologies is Prohibited for the NIH Peer Review Process
(NOT-OD-23-149)
National Institutes of Health
General Notices
- Notice of Pre-Application Webinar for PAR-23-155: Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
(NOT-CA-23-073)
National Cancer Institute
- Termination of the Requirement for COBRE, INBRE, IDeA-CTR, and NARCH Awards to Provide Supplemental Annual Reports through the Scientific Information Reporting System (SIRS)
(NOT-GM-23-046)
National Institute of General Medical Sciences
- Notice of NHLBI Participation in RFA-NS-22-022 "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)"
(NOT-HL-23-092)
National Heart, Lung, and Blood Institute
- Notice of NHLBI Participation in RFA-NS-22-023 "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)"
(NOT-HL-23-093)
National Heart, Lung, and Blood Institute
- Notice of NHLBI Participation in RFA-NS-22-024 "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)"
(NOT-HL-23-094)
National Heart, Lung, and Blood Institute
- Notice of NHLBI Participation in RFA-NS-22-025 "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
(NOT-HL-23-095)
National Heart, Lung, and Blood Institute
- Notice of Pre-Application Technical Assistance Webinar for RFA-MD-23-011, "NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 - Clinical Trial Optional)
(NOT-MD-23-017)
National Institute on Minority Health and Health Disparities
- Notice of Early Termination of NOT-TR-21-017, Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
(NOT-TR-23-023)
National Center for Advancing Translational Sciences
- Notice of Early Termination of NOT-TR-21-022, Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
(NOT-TR-23-024)
National Center for Advancing Translational Sciences
Notice of Changes to Funding Opportunities
- Notice of Early Expiration of NOT-AG-23-015, "Notice of Special Interest (NOSI): Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease"
(NOT-AG-23-031)
National Institute on Aging
- Notice of Correction to Agency Routing Identifier for NOT-CA-23-060 "Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology"
(NOT-CA-23-074)
National Cancer Institute
- Notice of NINR Participation in RFA-NS-24-015, HEAL Initiative Partnerships to Advance INterdisciplinary (PAIN) Training in Clinical Pain Research: The HEAL PAIN Cohort Program (T90/R90 Independent Clinical Trial Not Allowed)
(NOT-NR-23-011)
National Institute of Nursing Research
- Notice of Change to Funding Opportunity: RADx-UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)
(NOT-OD-23-138)
National Institute on Drug Abuse
- Notice of Change to Funding Opportunity: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)
(NOT-OD-23-141)
National Institute on Drug Abuse
- Notice of Change to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) in Award Information
(NOT-TR-23-022)
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed)
(NOT-NS-23-082)
National Institute of Neurological Disorders and Stroke
- Notice of Intent to Publish a Funding Opportunity Announcement for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
(NOT-NS-23-090)
National Institute of Neurological Disorders and Stroke
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Notices of Special Interest
- Notice of Special Interest (NOSI): Administrative Supplement Program to Help Develop Alzheimers-Focused NIH Grants
(NOT-AG-23-032)
National Institute on Aging
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Notice of Special Interest (NOSI): HIV Cure-Related Research in Diverse Populations
(NOT-AI-23-046)
National Institute of Allergy and Infectious Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
- Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives
(NOT-AI-23-049)
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials
(NOT-CA-23-071)
National Cancer Institute
Funding Opportunities
- Simultaneous and Synergistic Multi-Target Validation for Alzheimers Disease-Related Dementias (R61/R33 Clinical Trial not allowed)
(PAR-23-195)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
(PAR-24-210)
National Institute of Mental Health
- CCRP Initiative: Chemical Threat Agent Exposure Resource and Coordination Core (ExRC) (U2C Clinical Trial Not Allowed)
(RFA-ES-23-009)
National Institute of Environmental Health Sciences
National Eye Institute
National Institute of Allergy and Infectious Diseases
National Institute of Neurological Disorders and Stroke
- Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed)
(RFA-HG-23-024)
National Human Genome Research Institute
- Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
(RFA-HG-23-026)
National Human Genome Research Institute
- Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed)
(RFA-HG-23-027)
National Human Genome Research Institute
Office of the Director, NIH
- The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)
(RFA-HL-24-010)
National Heart, Lung, and Blood Institute
National Cancer Institute
- The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-HL-24-011)
National Heart, Lung, and Blood Institute
National Cancer Institute
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
(RFA-OD-23-019)
Office of the Director, NIH
- Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36)
(RFA-OD-23-020)
Office of the Director, NIH
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail)(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail)(link sends e-mail).